5 Most Promising Cancer Stocks According to Analysts
In this piece, we will take a look at the five most promising cancer stocks according to analysts.
Theseus Pharmaceuticals Inc. (THRX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 17,713,600 | $71,740,080 | 1.43% | |
| 2. | Tang Capital Management Kevin C. Tang | 3,255,026 | $13,182,855 | 1.21% | |
| 3. | Lynx1 Capital Management Weston Nichols | 702,415 | $2,844,781 | 1.11% | |
| 4. | Highbridge Capital Management Glenn Russell Dubin | 616,860 | $2,498,283 | 0.1% | |
| 5. | Beryl Capital Management David Alexander Witkin | 288,887 | $1,169,992 | 0.64% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.05 | 151,450 | Large Shareholder, Director | 650,600 | 2023-07-17 | Filing | |
| $3.05 | 328,482 | Large Shareholder, Director | 17,063,000 | 2023-07-17 | Filing | |
| $3.05 | 151,450 | Large Shareholder, Director | 650,600 | 2023-07-17 | Filing | |
| $3.05 | 328,482 | Large Shareholder, Director | 17,063,000 | 2023-07-17 | Filing | |
| $2.97 | 176,550 | Large Shareholder | 1,385,825 | 2023-07-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,108,796 | $16,640,624 | 22.67% | |
| 2. | 2,118,051 | $8,578,107 | 0.45% | |
| 3. | 1,425,234 | $5,772,198 | 0% | |
| 4. | 1,108,320 | $4,488,696 | 3.39% | |
| 5. | 795,549 | $3,221,973 | 0% |
News See All
5 Best New Penny Stocks to Buy Now
Earlier this month, Thoughtworks Holding, Inc. (NASDAQ:TWKS) announced Q2 results. GAAP EPS in the quarter came in at -$0.04, missing estimates by $0.06.
5 Oversold Penny Stocks To Buy
Earlier this month Rimini Street, Inc. (NASDAQ:RMNI) posted Q2 results. GAAP EPS in the quarter came in at $0.05, in-line with analyst estimates.
Hedge Fund and Insider Trading News: Crispin Odey, Pine River Capital Management, Alden Global Capital, True Arrow Capital Management, Theseus Pharmaceuticals, Inc. (THRX), Fastenal Co (FAST), and More
Pine River Capital Management (Pine River), a global relative value alternative asset manager, has appointed Abby Mongeon as a Repo Trader.
Thomas Steyer's Farallon Capital is Buying These 10 Stocks
In this article, we discuss 10 stocks that Thomas Steyer’s Farallon Capital is buying.
Should You Buy Theravance Inc (THRX)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
What Happened To Billionaire Seth Klarman's Top Biotech Picks In The Third Quarter?
Some investors think billionaire Seth Klarman is the next Warren Buffett. Given that Klarman's $31 billion fund, Baupost Group, has achieved average annual returns of 17% a year for over 30 years, ...
Smart Money Don't Bet on Three Biotech Stocks that Slumped Today and You Should Not Too
Smart money have been warning about the burst of the biotech bubble for a while now and it looks like they have been right on the money.
Billionaires Richard Perry and Seth Klarman Think Alike On American International Group Inc (AIG), Cheniere Energy Inc (LNG), Micron Technology Inc (MU), More
After compiling and analyzing the most recent 13F filings of hedge funds, we have found that Richard Perry’s Perry Capital and Seth Klarman’s Baupost Group keep around 14% of their portfolios invested...
Billionaire Klarman's Top Small-Cap Picks: ViaSat Inc., Theravance Inc., PBF Energy
The Baupost Group is a Boston-based hedge fund founded and operated by billionaire Seth Klarman.
Billionaire Hedge Funds
